J&J says FDA cancels review of antipsychotic drug

Sat, 22 Jul 2006 02:54 AM EST

... LOS ANGELES (Reuters) - Johnson & Johnson said on Friday that the U.S. Food and Drug Administration has canceled a planned advisory committee review its experimental drug paliperidone ER, a continuous release pill for treatment of schizophrenia. ...